Thoracic Malignancy / Biomarker
Molecular and Precision Oncology, Cancer Immunology
Lung Cancer; Malignant Pleural MesotheliomaEpigeneticsNon-coding RNABiomarkersCirculating free DNA/RNAcircRNAPollution
Contact Information:
Steven Gray, PhD
Senior Clinical Scientist (SJH)
Clinical Senior Lecturer (TCD)
Adjunct Senior Lecturer (TUD)
Thoracic Oncology Research Group
Central Pathology Laboratory, CPL30
St James's Hospital D08 RX0X
Dublin
Team Members:
Anne Keogh (working toward an MD)
Main Funders:
Health Research Board, Target Lung Cancer (TLC), St James’s Hospital Foundation
Active research programmes:
Dr Gray’s research currently involves studies on:
1. Identification of biomarkers that may have prognostic value in lung cancer and mesothelioma
2. Epigenetic mechanisms underpinning drug resistance or affecting Immunotherapy in lung cancer.
3. Targeting Epigenetic Readers, Writers and Erasers for the treatment of Mesothelioma and Thoracic malignancy
4. Circulating free RNA/DNA
5. non-coding RNA repertoires (including circular RNAs) in Mesothelioma and Thoracic malignancy.